SIGNIFOR
Google image searchProduct monograph
Active ingredient
pasireotide (pasireotide diaspartate), 0.6 MG/ML
DIN: 02413302
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription
Company: RECORDATI RARE DISEASES CANADA INC
Date: 21-MAY-2020
ATC:
- H01 — PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, ATC/DDD, )
- H01C — HYPOTHALAMIC HORMONES (ATC, ATC/DDD)
- H01CB — Antigrowth hormones (ATC, ATC/DDD)
- H01CB05 — PASIREOTIDE (ATC/DDD)
Reference brand drug: Signifor
